| Basics |
|
RAPT Therapeutics, Inc.
|
| IPO Date: |
October 28, 2019 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$556.83M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.72 | 4.03%
|
| Avg Daily Range (30 D): |
$1.32 | 5.25%
|
| Avg Daily Range (90 D): |
$0.76 | 4.87%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.43M |
| Avg Daily Volume (30 D): |
.36M |
| Avg Daily Volume (90 D): |
.19M |
| Trade Size |
| Avg Trade Size (Sh.): |
95 |
| Avg Trade Size (Sh.) (30 D): |
67 |
| Avg Trade Size (Sh.) (90 D): |
74 |
| Institutional Trades |
| Total Inst.Trades: |
1,084 |
| Avg Inst. Trade: |
$1.65M |
| Avg Inst. Trade (30 D): |
$2.1M |
| Avg Inst. Trade (90 D): |
$2.24M |
| Avg Inst. Trade Volume: |
.01M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$1.59M |
| Avg Closing Trade (30 D): |
$1.89M |
| Avg Closing Trade (90 D): |
$2.22M |
| Avg Closing Volume: |
11.29K |
|
|
| News |
Oct 22, 2025 @ 3:12 AM
RAPT Therapeutics Announces Pricing of Public Offe...
Source: Rapt Therapeutics, Inc.
|
Oct 19, 2025 @ 12:00 PM
RAPT Therapeutics to Report Topline Data from Phas...
Source: Rapt Therapeutics, Inc.
|
Sep 29, 2025 @ 9:00 AM
RAPT Therapeutics Announces FDA Clearance of IND A...
Source: Rapt Therapeutics, Inc.
|
Jun 23, 2025 @ 12:00 PM
RAPT Therapeutics Names Two Industry Veterans to i...
Source: Rapt Therapeutics, Inc.
|
Jan 6, 2025 @ 1:00 PM
RAPT Therapeutics Names Lori Lyons-Williams Cha...
Source: Rapt Therapeutics, Inc.
|
| Financials |
| |
TTM |
Q1 2025 |
Q4 2024 |
|
Basic EPS
|
$-.65
|
$-.08
|
$-1.22
|
|
Diluted EPS
|
$-.65
|
$-.08
|
$-1.22
|
|
Revenue
|
$ M
|
$ M
|
$ M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$ -17.64M
|
$ -17.17M
|
$ -53.25M
|
|
Operating Income / Loss
|
$ -19.54M
|
$ -19.27M
|
$ -54.47M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$ -127.85M
|
$ M
|
$ 131.84M
|
|
PE Ratio
|
|
|
|
|
|
|
